Incidence of genital warts among the Hong Kong general adult population by Lin, Chunqing et al.
RESEARCH ARTICLE Open Access
Incidence of genital warts among the Hong Kong
general adult population
Chunqing Lin







Background: The objective of this study is to estimate the incidence of genital warts in Hong Kong and explore a
way to establish a surveillance system for genital warts among the Hong Kong general population.
Methods: A total of 170 private doctors and all doctors working in the 5 local Social Hygiene Clinics (SHC)
participated in this study. During the 14-day data collection period (January 5 through18, 2009), the participating
doctors filled out a log-form on a daily basis to record the number of patients with genital warts. The total
number of new cases of genital warts presented to private and public doctors in Hong Kong was projected using
the stratification sampling method.
Results: A total of 721 (0.94%) adults presented with genital warts to the participating doctors during the two-
week study period, amongst them 73 (10.1%) were new cases. The projected number of new cases of genital warts
among Hong Kong adults was 442 (297 male and 144 female) during the study period. The incidence of genital
warts in Hong Kong was estimated to be 203.7 per 100,000 person-years (respectively 292.2 and 124.9 per 100,000
person-years for males and females).
Conclusions: The incidence of genital warts is high among adults in Hong Kong. The study demonstrates the
importance of collecting surveillance data from both private and public sectors.
Background
Genital warts (condylomata acuminata) are highly infec-
tious benign epithelial mucosal tumors caused by
human papillomavirus (HPV), most commonly types 6
and 11[1,2]. Clinical symptoms of genital warts include
itching, burning, tenderness at the warts site and anal,
urethral, or vaginal bleeding or discharge[3]. Although
not life threatening, genital warts exact a significant
financial toll on the health care system and pervasive
psychological stress and shame among the patients[4].
Genital warts is one of the most commonly occurring
sexually transmitted diseases (STDs). The prevalence of
genital warts has been estimated to be 1% in the sexu-
ally active population[5]. T h e r ep r e v a l e n c eo ft h ed i s -
eases has been increasing throughout Europe[6,7]. In
the United Kingdom, the prevalence of genital warts
increased by approximately 25% from 1996 to 2005[8].
Surveillance of genital warts as well as other STDs
should provide accurate and timely population estimates
on prevalence and incidence trends[9]. Most of the STD
surveillance studies have focused only on some specific
high risk groups [10] as population-based surveys are
difficult to implement[11]. In many countries, case
reporting remains the mainstay of STD surveillance and
very limited data are obtained from private patients[12].
In Hong Kong, surveillance data on STDs are solely
obtained from the Social Hygiene Clinics (SHC) of the
Department of Health. A surveillance study reported a
total of 2,276 genital wart cases in Hong Kong in 2008
[13]. The number and proportion of genital wart cases
being diagnosed by local private doctors remain
unknown. In addition, the incidence of genital warts was
not documented in Hong Kong.
This study investigated the total number of new geni-
tal wart cases among patients who sought consultations
from three types of private doctors, as well as public
doctors working in the SHC, during a 14-day study per-
iod. The total number of new genital wart cases present-
ing their symptoms to Hong Kong doctors during the
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was to estimate the incidence of genital warts among
general adult population in Hong Kong. A secondary
objective of the study was to examine the feasibility of
setting up a surveillance system for genital warts among
the Hong Kong general population.
Methods
Sampling frame
In Hong Kong, about 56% of the physicians work in
the private sector. The private system provides 20% of
the inpatient medical care, 11% of hospital beds, and
70% of the outpatient visits. Patients generally seek pri-
vate outpatient medical care by self-referral. Medical
fees are usually paid at the time of service, with less
than 10% of fees being paid directly by insurance com-
panies[14]. Three types of private practitioners partici-
pated in the study: general practitioners (GP), obstetric
and gynaecology (O&G) doctors and dermatologists
and venereology (D&V) doctors. The majority of the
local patients seeking consultation for STDs from pri-
vate doctors would be seen by such private doctors
[15,16]. A previous study which was commissioned by
the Department of Health in Hong Kong in June 2007
requested the aforementioned types of private doctors
and public doctors to record information of all patients
presenting with STD symptoms within a specific per-
iod of 15 days[17]. In that study, the sampling frame
of the private doctors included all members of the
Hong Kong Association of Specialists in Dermatology
and all O&G and GP doctors whose valid contact
information was listed in the websites of the Medical
Council of Hong Kong http://www.mchk.org.hk/doc-
tor/index.htm, the Yellow Pages http://www.yp.com.hk/
home/en/html/main/home.aspx and The Hong Kong
Doctors Homepage http://www.hkdoctors.org of the
Hong Kong Medical Association. Some research assis-
tants then verified the validity of the contact informa-
tion by phone or by mail. A total of 277 private
doctors (247 GPs, 14 O&G doctors and 16 D&V doc-
tors) participated in the 2007 study (representing 9.3%,
7.9% and 30.2% of all doctors with valid contact infor-
mation) and all of them were invited to participate in
the present study.
There are a total of eight Social Hygiene Clinics
(SHC) in Hong Kong which are responsible for the pre-
vention and control of STDs. SHC provide walk-in ser-
vice for consultation, counselling and medical treatment
for patients with STDs. Staff of the SHC carry out con-
tact tracing, health education and outreach activities to
control the spread of STDs[18]. In collaboration with
the Department of Health, all doctors in five major
SHC, out of the eight clinics, participated in the present
study.
Recruitment procedure
An invitation package which included a self-explanatory
introduction letter, a sample log-form and a reply slip
was sent to each of the aforementioned 277 doctors
from November to December 2008. All prospective par-
ticipants were requested to fill out the reply slip and
return it to the research team by fax or mail. About one
week after the invitation letter was sent, a follow-up tel-
ephone call was made to all prospective participants by
a team of experienced interviewers to confirm their par-
ticipation status. With respect to unanswered calls, at
least four other independent calls were made on differ-
ent hours in different days before the contact number
was considered as an invalid one.
Data collection
A study kit, which contained an instruction manual, a
set of log forms and a reminder sheet, was delivered to
the participants’ clinic by a research assistant one week
prior to the commencement of the data collection time
period. The instruction manual introduced the objective
of the study and the data collection procedure in detail
to the doctors. Doctors in the SHS clinics received
training on how to fill out the log-form. An enquiry
hot-line was also launched during the study period. The
anonymous log-form was designed by the research team
to record the number of patients seen by the doctor on
a particular day and the number of adult patients (aged
18 or above) presenting with genital warts to the doctor.
The patients’ names or other personal identifiable infor-
mation were not collected. Genital warts were defined
as clinical features of warts in or around anogenital area
which include internal/external genitalia, perineum and
perianal region. Diagnosis of genital warts is primarily
based on clinical judgments and no laboratory tests
were required. The patients with genital warts were
asked whether he/she had ever noted similar symptoms
before or been diagnosed with genital warts previously
in any health care facilities. The cases with no past
symptoms or clinical diagnosis of genital warts were
defined as new cases. Demographic information such as
gender and year of birth of the genital wart cases was
recorded.
During the 14-day data collection period (January 5 to
January 18, 2009), all participating doctors were required
to fill out the log-form on a daily basis and fax it back
to the research office. If the log-form was not received
from a particular clinic on time, reminder calls were
made by the research team to ensure the completeness
of data. Long sensitive questionnaires were avoided in
order to ensure the data accuracy. Research assistants
cross-checked every form on a daily basis and contacted
the doctor involved in the case of any unclear entries.
The completed log forms were sent to the research
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cation. As an incentive, a supermarket coupon (HK$200
or about US$25) was sent to participating doctors who
completed the study. Ethics approval was obtained from
the Chinese University of Hong Kong.
Data analysis
The total number of patients presenting with genital
warts to local private doctors during the data collection
period was projected using the stratification sampling
method[19,20]. GPs were stratified in 18 strata accord-
ing to the district-board classification system. Hence,
there were a total of 20 strata (18 GP strata + 1 O&G
doctor stratum + 1 D&V doctor stratum) for private
doctors. The total numbers of GPs in each of the 18 dis-
tricts and the number of D&V and O&G were obtained
from the Department of Health. The projected number
of patients in a stratum is hence:
N
Total Number of doctor in the stratum
Number of participa
=
t ting doctor in the stratum
N × ’
N: projected number of patients in the stratum
N’: Observed number of patients in the stratum
The territory-wide number of patients presenting with
genital warts to private doctors during the study period
was estimated by summing up the figures projected for
all the 20 strata.
The number of adult genital warts patients seen by
doctors of the five SHC during the study period was
used to project the total number of adult patients seen
by doctors of all eight SHC in the territory, according to
the distribution of the number of genital warts cases
presented in the eight individual clinics identified from
a previous STD surveillance study conducted in 2007
[17]. Such data were obtained from the local Depart-
ment of Health. An important assumption was made
that the number of genital warts patients seen by the
participating doctors was representative of those seen by
all doctors territory-wide.
The total number of new adult genital warts cases in
Hong Kong presenting with symptoms to local private
and public doctors during the study period was obtained
by summing up the projected number of patients seen
by private and public doctors. Bootstrap methods were
used to estimate the respective 95% confidence intervals
[21]. The intervals were calculated using Matlab V7.1
(the MathWorks, Inc.), based on a reasonably large
number of 30000 bootstrap replications.
The incidence of genital warts was estimated using the
total projected number of new genital warts cases
detected by public and/or private doctors in Hong Kong
during the study period, divided by the person-year
exposure of the Hong Kong adult population age 18 and
above during the same time period. According to the
2006 census, the sizes of the local male, female and total
adult population age 18 and above years old were
respectively 2,650,340, 3,006,691 and 5,657,031. The per-
son-year exposure to the risk of developing new genital
warts during the study period hence equals to the adult
population size multiplied by 14/365.
Results
Participating doctors
A total of 215 GPs, 14 O&G doctors and 16 D&V doc-
tors with valid contact information were invited to join
the study and 157 GPs, seven O&G doctors and six
D&V doctors participated in the study; the response
rates were hence 73.0%, 50.0% and 37.5% for the three
type of private doctors. Amongst the 170 participating
private doctors, 140 (82.4%) were male. During the
study period, a total of 76,060 patients visited the parti-
cipating private and public doctors, amongst whom
73,036 were seen by private doctors and 3,024 were
seen by public doctors (Table 1).
Profile of the genital warts cases
Amongst all patients visiting the participating doctors
(76,060), 721 (0.94%) presented with genital warts dur-
ing the study period. The majority (82.0%) of them were
male. Approximately one tenth (73) of the 721 episodes
were new cases. Amongst these new cases, 27 (37%)
were identified by private doctors and 46 (63%) by pub-
lic doctors (public: private ratio = 1.70: 1). Amongst the
27 patients who were identified by private doctors, 17
were identified by GPs and 10 by D&V doctors. The
majority (79.5%) of the new cases were male (Table 1).
About one third (31.5%) of them were older than 50
and 28.8% were between 18 and 30 years of age. Com-
paring new genital warts cases identified by private or
public doctors, no statistically significant differences in
age and gender were found (Table 2).
Projected territory-wide number and incidence of new
genital wart cases
The number of Hong Kong adults (18 or above years
old) who presented with new genital warts to all local
doctors during the study period was projected - 384
(95% CI: 208 to 590) for private patients and 58 (95%
CI: 53 to 96) for public patients (private to public ratio
= 6.62:1). Only respectively 15.4% and 7.6% of the pro-
jected male and female new genital warts cases were
detected by public doctors (Table 3). The incidence of
genital warts detected by either public or private doctors
for the entire Hong Kong adult population is estimated
to be 203.70 per 100,000 person-years (292.16 and
124.86 per 100,000 person-years respectively for males
and females; Table 3).
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The estimated incidence of genital warts was around
203.7 per 100,000 person-years, which is higher than
those obtained from a number of international studies.
A study reviewed the medical records obtained from
899 gynaecologists, dermatologists and urologists in
Spain and provided an estimated incidence of 118 per
100,000 person-years[22]. In Canada, the incidence of
genital warts was estimated to be 107 per 100,000 per-
son-years in 1999, which increased slightly to 126 per
100,000 person-years in 2006[23]. In Germany, the inci-
dence of genital warts was 113.7 per 100,000 person-
years, based on the data collected from some gynecolo-
gists, dermatologists, and urologists seeing patients with
genital warts[24]. The data of the previous studies were
obtained retrospectively from clinical and health insur-
ance databases. The current study is however, one of
the few prospective studies involving both private and
public doctors. This is also the only longitudinal study
on incidence of genital warts among Chinese general
population. With the different data collection methods
involved in different studies, direct comparisons should
however, be made with caution.
A true population census of genital warts incidence is
extremely difficult because of the variable spectrum of
disease, patient embarrassment in presenting for treat-
ment or self reporting to a survey, the transient nature
of the disease and variety of health specialists from
whom patients may seek assistance (including pharma-
cists, alternative/traditional medicine practitioners in
addition to physicians). Whether or not attempting a
true population census, or representative sample, is
worthwhile given the barriers really depends on the pur-
pose for collecting the information (e.g. planning treat-
ment services vs. burden of disease data for cost
effectiveness analysis vs. vaccine monitoring). In relation
to the latter, one extremely useful outcome of the pre-
sent study could be to identify enthusiastic practitioners
who see young patients presenting with warts who
could form the basis of an ongoing surveillance system
to monitor trends in presentations with warts at their
practices following the introduction of quadrivalent
HPV vaccine to the population. This would be more
efficient than attempting to repeat the survey over a
large number of variably participating practices over
time.
Table 1 Number of patients presenting the genital warts symptoms in the studied clinics in Hong Kong during the
study period (January 5 to January 18, 2009)




Number of genital wart
cases
Number of new genital wart
cases
N (%) * N (%) *
Private doctors 73,036 96 (0.13) 27 (0.04)
GP (157/215) 69,671 64 (0.09) 17 (0.02)
O&G doctor (7/14) 770 16 (2.08) 0 (0.000)
D&V doctors (6/16) 2,595 16 (0.62) 10 (0.39)
Public doctors 3,024 625 (20.67) 46 (1.52)
Total 76,060 721 (0.95) 73 (0.10)
* The percentages of the genital warts symptoms were calculated by the number of patients with the genital wart symptoms divided by the total number of
patients who sought medical care during the study period.
Table 2 The gender and age distributions of patients presenting new genital warts symptoms in the public sector
versus the private sector in Hong Kong (2009)
All (N = 73) Private* (N = 27) Public
# (N = 46) c
2
N (%) N (%) p-value
Gender
Male 58 21 (78) 37 (80) 0.79
Female 15 6 (22) 9 (20)
Age group
<18 0 0 (0) 0 (0) 0.07
18-30 21 4 (15) 17 (37)
31-40 19 11(41) 8 (17.)
41-50 9 4 (15) 5 (11)
>50 23 7 (26) 16 (35)
Missing 1 1 (4) 0 (0)
* Includes those patients who sought medical care in the private sector: General Practices, Obstetrics & Gynaecology and Dermatology & Venereology
# Includes those patients who sought medical care in the SHS clinics of the Department of Health
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Italy, Portugal and China, STD surveillance data were
obtained from case-reporting made by governmental
departments[12,25]. Our results suggested that those
systems relying only on data obtained from public
clinics are likely to under-estimate the incidence of geni-
tal warts. In Hong Kong only 13.1% of such new cases
would seek consultation from public doctors. The study
demonstrates the feasibility of launching periodic sur-
veillance on genital warts both in the private and public
sectors in Hong Kong. It is recommended that similar
exercises should be repeated every two to three years so
that trends of the disease could be traced.
The findings that males in Hong Kong had higher
incidence of genital warts than females were consistent
with the high prevalence of risk behaviours observed in
the male general population[26]. Two types of HPV vac-
cine is currently available,[27,28] and quadrivalent vac-
cine’s efficacy in protecting against infection and disease
caused by targeted HPV types has been established both
for men and women[29,30]. This study hence gives an
important piece of baseline information about the epide-
miological burden of genital warts, which can be used
for evaluating the impact of future vaccination promo-
tion programs at a population level.
The study has several limitations. First, the response
rates of the O&G and D&V doctors were somehow dis-
appointing in this study and better collaboration with
relevant professional associations is required for future
studies of the type. Similarly, the overall response rate
for the three types of private doctors was only 69%. We
therefore have to assume that the number of new
genital wart cases seen by the participating doctors was
a representative sample of all such patients in Hong
Kong. Although the gender, type and clinic location of
the participating doctors was comparable to those doc-
tors who did not participate in this study, the aforemen-
tioned assumption could still be invalid. We speculate
that participating doctors may be those who have more
interest or expertise in genital warts and who may
therefore see more cases. In addition, the study sample
was based on responders to a 2007 study, newly gradu-
ated doctors (since 2007) would not be included in the
sample. Second, the data collection period (two weeks)
was relatively short, due to the limit of funding the
resources. The numbers of patients presenting the geni-
tal warts symptoms might be biased because of seasonal
change or major festival activities. There may also be a
possible increased detection of warts that would other-
wise not be diagnosed due to the ongoing prompting of
the clinicians through the daily reporting mechanism
during the study period. Third, although genital warts
are easy to identify by observation, we should admit that
it is a limitation to use syndromic management
approach in case identification. Lastly, only three cate-
gories of private doctors were included into this study
whilst other types of specialists may also have managed
new genital warts cases during the study period, though
such numbers may be relatively small.
Conclusions
The methodology of the study offers a feasible approach
for setting up a surveillance system by including data
from both private and public practitioners. The data
Table 3 Projected number of patients presenting new genital wart symptoms and incidence among Hong Kong adults
(2009)




Private 21 251 246.91
Public 37 46 101,657 45.25
All 58 297 292.19
Female
Private 6 133 115.33
Public 9 11 115,325 9.54
All 15 144 124.86
All
Private 27 384 176.97
Public 46 58 216,982 26.73
All 73 442 203.70
1. Person-year exposure (person-year) among those aged 18 or above = (total number of persons aged 18 or above in HK) * (14 days/365 days), where the total
number of persons aged 18 or above in HK for male, female and all were respectively 2,650,340, 3,006,691 and 5,657,031 (source by 2006 population by-census).
2. Incidence rate (per 100,000 person-year) of new genital warts presented to doctors among Hong Kong adults aged 18 or above = (Projected no. of new
cases)/(Person-year exposure (person-year))*100,000
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control of genital warts in Hong Kong. It is necessary
that both public and private doctors should participate
in the STD surveillance in Hong Kong.
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